BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2183160)

  • 1. Retrospective analysis of ras gene activation in myeloid leukemic cells.
    Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP
    Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
    Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
    Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
    Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
    Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-ras mutations in radiation-induced murine leukemic cells.
    Rithidech KN; Dunn JJ; Gordon CR; Cronkite EP; Bond VP
    Blood Cells Mol Dis; 1996; 22(3):271-80. PubMed ID: 9075579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia.
    Toksoz D; Farr CJ; Marshall CJ
    Oncogene; 1987; 1(4):409-13. PubMed ID: 3330783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct sequencing of amplified genomic fragments documents N-ras point mutations in myeloid leukemia.
    Collins SJ
    Oncogene Res; 1988 Sep; 3(2):117-23. PubMed ID: 3067186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.
    Hirai H; Kobayashi Y; Mano H; Hagiwara K; Maru Y; Omine M; Mizoguchi H; Nishida J; Takaku F
    Nature; 1987 Jun 4-10; 327(6121):430-2. PubMed ID: 3295562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of ras oncogene in myelodysplastic syndrome and acute myelogenous leukemia].
    Hirai H; Hirano N; Yazaki Y
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1090-7. PubMed ID: 2053767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
    Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
    Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
    Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
    Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS mutations in patients following cytotoxic therapy for lymphoma.
    Carter G; Hughes DC; Clark RE; McCormick F; Jacobs A; Whittaker JA; Padua RA
    Oncogene; 1990 Mar; 5(3):411-6. PubMed ID: 2179819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
    Shen S; Passioura T; Symonds G; Dolnikov A
    Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes in multiple myeloma: point mutation of N-ras.
    Paquette RL; Berenson J; Lichtenstein A; McCormick F; Koeffler HP
    Oncogene; 1990 Nov; 5(11):1659-63. PubMed ID: 2267133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome.
    Horiike S; Misawa S; Nakai H; Kaneko H; Yokota S; Taniwaki M; Yamane Y; Inazawa J; Abe T; Kashima K
    Leukemia; 1994 Aug; 8(8):1331-6. PubMed ID: 8057669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements.
    Liang DC; Shih LY; Fu JF; Li HY; Wang HI; Hung IJ; Yang CP; Jaing TH; Chen SH; Liu HC
    Cancer; 2006 Feb; 106(4):950-6. PubMed ID: 16404744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of K-ras codon 12 in blood samples of patients with acute myeloid leukemia.
    Preston R; Däbritz J; Hänfler J; Oettle H
    Leuk Res; 2010 Jul; 34(7):883-91. PubMed ID: 20304488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
    Kurosawa M
    Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.